Trinity Biotech plc (ADR) - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TRIB Nasdaq 2835 https://www.trinitybiotech.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trinity Biotech plc (ADR)

Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry - Jan 9th, 2023 1:00 pm
Trinity Biotech plc (NASDAQ:TRIB) Q3 2022 Earnings Call Transcript - Dec 22nd, 2022 3:36 am
Trinity Biotech plc (NASDAQ:TRIB) Q2 2022 Earnings Call Transcript - Dec 22nd, 2022 3:35 am
Trinity Biotech Announces Q3 2022 Financial Results - Dec 15th, 2022 2:05 pm
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results - Dec 9th, 2022 10:35 am
Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference - Nov 30th, 2022 10:50 am
Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance - Nov 3rd, 2022 1:00 pm
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results - Nov 1st, 2022 1:15 pm
Trinity Biotech Announces the Appointment of Tom Lindsay to its Board of Directors - Oct 26th, 2022 12:30 pm
Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO - Oct 3rd, 2022 12:50 pm
Trinity Biotech Announces Results of AGM - Sep 30th, 2022 1:00 pm
Is There Now An Opportunity In Trinity Biotech plc (NASDAQ:TRIB)? - Aug 28th, 2022 12:10 pm
Estimating The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB) - Jul 18th, 2022 12:29 pm
Trinity Biotech Announces Quarter 1 2022 Financial Results - Jun 30th, 2022 1:07 pm
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results - Jun 29th, 2022 9:20 pm
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test - May 20th, 2022 1:20 pm
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea - May 3rd, 2022 10:50 pm
Trinity Biotech Stock Surges After $45M Capital Infusion From Korea-Based Firm - Apr 11th, 2022 3:45 pm
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results - Apr 11th, 2022 1:00 pm
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea - Apr 11th, 2022 12:15 pm